Lilly Support Services for Kisunla is here for you

Lilly Support Services is a patient support program that’s committed to offering you customized support and helping you navigate your treatment experience with Kisunla.

Lilly Support Services can partner with you to help you better understand:

Your treatment costs

How to get started with Kisunla

How to navigate treatment as smoothly as possible

Use this tool to find an infusion center.

For help with scheduling an infusion appointment, you can also give us a call.

Questions about Kisunla? We’re here to help.

Call Lilly Support Services:
1-800-LillyRx (1-800-545-5979)
Monday to Friday, 9:00 AM-6:00 PM ET

Want to help others? You can help by sharing your Kisunla story with us. Give us a call and let us know you’d like to leave a testimonial.

Looking for additional support?

You are not alone. We are here to connect you with resources and organizations that can offer additional support on your journey, in person or online.

This information has been provided by the listed organizations, and Lilly is not responsible for the content. Its use on this site is not intended to serve as an endorsement of the listed organizations. All third party organization names and other trademarks are the property of their respective trademark owners. Those trademark owners are not affiliated with Lilly and they do not sponsor or endorse this material.

Alzheimer’s Association is here for you, day and night. Our programs and support services connect you with peers and professionals to help you make the plans and adjustments necessary to live your best life for as long as possible.

See here for the Alzheimer’s Association’s 24/7 helpline, available 365 days a year. Through this free service, specialists and clinicians offer confidential support in areas such as decision-making, crisis assistance, and education on day-to-day issues you may face.

The mission of CaringKind is to create, deliver, and promote comprehensive and compassionate care and support services for individuals and families affected by Alzheimer’s disease and related dementias, and to eliminate Alzheimer’s disease through the advancement of research. We achieve our mission by providing programs and services for individuals with dementia, their family and professional caregivers, increasing public awareness, collaborating with research centers, and informing public policy through advocacy.

See here for Journey Together, a specialized workshop for a small group of people adjusting to life with memory and/or cognitive changes. Virtual sessions are facilitated by an experienced CaringKind dementia specialist, providing support and valuable information each week. Meaningful discussions focus on topics related to understanding and living with changes. Sessions include mind-, body- and soul-enriching activities, and topical discussions like: Living with Change, Connecting with Community, What is Dementia?, Relationships, Grief and Loss, Self-care and Tell Your Story.

The mission of the Alzheimer’s Foundation of America (AFA) is to provide support, services and education to individuals, families and caregivers affected by Alzheimer’s disease and related dementias nationwide, and fund research for better treatment and a cure.

See here for the AFA’s Alzheimer’s and dementia support group offerings, including a 6-week support group for persons newly diagnosed with Alzheimer’s or dementia.

SAFETY SUMMARY WITH WARNINGS

Warnings - Kisunla can cause Amyloid-Related Imaging Abnormalities or "ARIA." This is a common side effect that does not usually cause any symptoms, but serious symptoms can occur. ARIA can be fatal. ARIA is most commonly seen as temporary swelling in an area or areas of the brain that usually goes away over time. Some people may also have spots of bleeding on the surface of or in the brain and infrequently, larger areas of bleeding in the brain can occur. Although most people do not have symptoms, some people have:

Headache
Dizziness
Nausea
Difficulty walking

Confusion
Vision changes
Seizures

Some people have a genetic risk factor (homozygous apolipoprotein E ε4 gene carriers) that may cause an increased risk for ARIA. Talk to your healthcare provider about testing to see if you have this risk factor.

You may be at higher risk of developing bleeding in the brain if you take medicines to reduce blood clots from forming (antithrombotic medicines) while receiving Kisunla. Talk to your healthcare provider to see if you are on any medicines that increase this risk.

Your healthcare provider will do magnetic resonance imaging (MRI) brain scans before and during your treatment with Kisunla to check you for ARIA. You should carry information that you are receiving Kisunla, which can cause ARIA, and that ARIA symptoms can look like stroke symptoms. Call your healthcare provider or go to the nearest hospital emergency room right away if you have any of the symptoms listed above.

There are registries that collect information on treatments for Alzheimer’s disease. Your healthcare provider can help you become enrolled in these registries.

Warnings - Kisunla can cause serious allergic and infusion-related reactions. Do not receive Kisunla if you have serious allergic reactions to donanemab-azbt or any of the ingredients in Kisunla. Symptoms may include swelling of the face, lips, mouth, or eyelids, problems breathing, hives, chills, irritation of skin, nausea, vomiting, sweating, headache, or chest pain. You will be monitored for at least 30 minutes after you receive Kisunla for any reaction. Tell your healthcare provider right away if you have these symptoms or any reaction during or after a Kisunla infusion.

Other common side effects

Headache

Tell your healthcare provider right away if you have any side effects. These are not all of the possible side effects of Kisunla. You can report side effects at 1-800-FDA-1088 or www.fda.gov/medwatch.

Before you receive Kisunla, tell your healthcare provider:

About all medicines you take, including prescription and over-the-counter medicines, as well as vitamins and herbal supplements. Especially tell your healthcare provider if you have medicines to reduce blood clots from forming (antithrombotic medicines, including aspirin).
About all of your medical conditions including if you are pregnant, breastfeeding, or plan to become pregnant or breastfeed. Kisunla has not been studied in people who were pregnant or breastfeeding. It is not known if Kisunla could harm your unborn or breastfeeding baby.

How to receive Kisunla

Kisunla is a prescription medicine given through an intravenous (IV) infusion using a needle inserted into a vein in your arm. Kisunla is given once every 4 weeks. Each infusion will last about 30 minutes.

Learn more

For more information about Kisunla, call 1-800-LillyRx (1-800-545-5979) or go to kisunla.lilly.com.

This summary provides basic information about Kisunla. It does not include all information known about this medicine. Read the information given to you about Kisunla. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Kisunla. Your healthcare provider is the best person to help you decide if Kisunla is right for you.

DN CON BS APP

Kisunla^™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.

INDICATION

Kisunla™ (kih-SUHN-lah) is used to treat adults with early symptomatic Alzheimer’s disease (AD), which includes mild cognitive impairment (MCI) or mild dementia stage of disease.